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Objectives. We examined the reluthm between the level of 
urinary Cbrinopeplide A and the presence of angiographic intra- 
coronary tbmmbus in patients with unstable angina to determine 
whether this marker predicts active tbrombur rwmation. 
Backpund. Attlmgk it is known that tbmmbus plays a role 
in acute ischedc syndromes, a noninvasive methud to predict its 
presence in individual patients with unstable angina has not been 
determined. Fibrinopeptide A Is a polypeptlde cleuved from 
fibrinogen by thromtW and thus is o sensitive marker af ihmmbin 
activity and Rbrin generation. 
M&x&. Angiographic thrombus, graded 0 to 4. and the 
presence of ST segment depression or T wave invenlans, 0~ both, 
on the electrwrdiogram (FCC) were related to Bbrlnopeptlde A 
levels in 24 patients with rest angina of new ansei, IS wilh 
crescendo angina, f9 with stahk angina and 9 with chest patn hut 
without caronaty artery disease. All putknts had chest pain within 
the 24 b of sample acquisition. 
rigniliuntly (p 4 0.001) with the presence of a iillingdefwt (grade 
4 lntracoronsry thrombus) M contrast staining [grads 3). All 
patients with fibrinopeptide A a6 ng/mg creathdne showed grade 
3 to 4 thrumbus and 1.5 or 16 patients with levels ~6.0 nghng 
ereatinine exhibited angiographk evidence of thrombus (13 with 
grades 3 to 4). Patients with reversible ST changes 011 the ECG 
had significantly higher levels 0ffibrinopeptide A (p < O.OOl), and 
ST changes correlated significantly with the preswxe of angio- 
graphic thrombus (p < 0.001). Nonethekss, a dgnlfiunt minority 
of palients with unslPhk angina had neither angiagrapbic nor 
blachemieal evidence afthrombus. 
Resufls. The angiographk incidence of fhrombus wan signifi- 
cantly higher in patients wilh new onset of rest angina (679, p < 
0.001) and crescendo angina (So%, p < 0.001) as were fibrinqep 
tide A levels (p = 0.002). Fibrinopeptide A levels carrelated 
Conclusiant. Ekvated tibrinopcptide A kvels in unstable an- 
gina &k&d active intrucomnaq thrombus formatian aad were 
presenl in patknts with angina d new 0n.wt as well as crewen& 
angina. Reversibte ST chPngPs are accompanied by tbmmhtn 
activity and angiographie thrombus form&ii. However, a sk- 
able percentage of p&n& wtth tmstabk angina bad na &knee 
of thrombus and lhw patients may have had lnosknt pfatekt 
aggregation without lihrin thr0mhus rortttation. 
(J Am Cdl Caniiof 1993;21:692-9) 
Several studies utilizing angiography (I-S), angioscopy (61, 
biochemical assays (7-15) and pathology (16-18) have dem- 
onstrated that intracoronary thrombus formation plays a role 
in the pathogenesis of unstable angina pectoris. Coronary 
angiograms from patients with rest angina often exhibit 
complex lesion morphology postulated to represent a tis- 
sured plaque or superimposed thrombw, or both (19-21). In 
addition, a 34% to 68% incidence of angiographic lhrombus 
has been demonstrated in patients with unstable angina 
U-5)+ Because patients with unstable angina wifh thrombus 
formation may benefit from thromboiytic therapy (2,22X4), 
the early identification of thrombus ir important. 
Fibrinopeptide A, a poiypeptide cleaved from fibrinogen 
by thrombin (251, has no biologic function but is a sensitive 
marker of rhrombin activity and fibrin generation. Fibrino- 
peptide A disappears rapidly from the blood (26-29) but is 
excreted into the urine where it is relatively stable (27,30). 
Both 24-h and spot urine levels correlate with plasma tibrino- 
peptide A levels obtained concurrently (30.31). Although 
elevation of fibrinopeptide A levels, noted in some patients 
with unstable angina pectoris (7-10.32). has been postulated 
to result from intracoronary rhrombus formation, there are 
no data correlating the presence of coronary rhrombus and 
fihrinopeptide A levels. Accordingly, the present study was 
designed f0 evaluate whether elevated fibrinopeptide A 
levels predict angiographically documented intracoronary 
thrombus in ptients wilh unstable angina. From the Krannen tnrtilule of Cardiology. Depanment of Medicine cud 
‘Depaflmenl of Radiology. Indiana University DJuml oi Mcducine. Indianap 
ok. Indiana and tDepanment of Pathology. Velerans Aflairs and George 
Washington Universily Medical Ccntcn. Washington. D.C. Thus rludy was 
presented in PBI. at the 63rd Annual Scientific Sessions ofthe American Heart 
Methods 
Meetion of patients. All patients, recruited prospec- 
tively, who underwent coronary arteriography for suspected 
angina pectoris and gave informed consent were eligible for 
inclusion iq this study. Patients were excluded if conditions 
019% by the Amcricun College oPCardio og6y 
associated wtth elevated fibrinopeptide A levels were 
present: malignancy, infection. noncardiac thromboembo- 
km, intlammarory disease. aortic aneurysm or atrial fibnl- 
Mon. Patients with renal mcufficicncy (plasma creatinine 
EUI mg/dl), patients receiving an&x&ant therapy and 
patients with an acute myocardial infarction within the 
preceding month were also excluded. 
Definition of experimental groups. The clinical diagnosis 
of unstable angina was made before cardiac catheterizadon. 
If no coronary obstructions were observed the patient was 
placed in the control group. All patients had an episode of 
chest pain within the 24 h before tibrinopeptide 4 sample 
acquisition. The patients were classified into the iallowing 
groops: 
Grorrp I (rontro!prnup)r Patients with symptoms suggcs- 
tive of unstable angina pectoris without coronary artery 
disease or coronary artery spasm induced by ergonovine. 
Patients with a lesion 550% and without coronary artery 
spasm or a stress test positive for ischemia were excluded 
from this study after angiography. 
Gro!fp 2 (rtu$lr rrrrgino perturis): Patients with signifi- 
cant coronary artery disease and a stable angina pattern in 
the preceding 2 weeks who had had an episode of typical 
exertional chest pain within 24 h of sample acquisirion. 
Significant coronary disease was defined as the presence of 
270% stenosis in one or more coronary arteries or the 
presence of a ~50% lesion in a patient with a stress test 
positive for &hernia. 
Grottp 3 frmsmble cmgincr prctorisir A) Crcmmfo UP- 
gina: Patients with significant coronary artery disease with 
either an increase in the duration of their typical angina1 
attacks or angina1 attacks with progressively lesser degrees 
of activity within the preceding 2 weeks. Patients with a 
recent onset of rest angina were included in this group only 
if the rest angina was part of the escalating pattern of 
crescendoangina. BJ Rm nnginn of~m*onser: Patients with 
curonary artery disease with an onset of rest anginaepisodes 
within the preceding 2 weeks. All patients had had a stable 
course of angina pectoris before the onset of rest angina. The 
most recent episode of rest angina occurred 524 h before 
fibrinapeptide A sampling. 
The investigators were assigned to clinical. laboratory or 
angiographic groups. The clinician assigned the clinical 
diagnosis and evaluated and monitored electracardiogramr 
(ECGs) without knowledge of librinopepride A and angio- 
graphic results. The &cuts’ ECGs were evaluated for the 
presence of ST segment depression or T wave inversion 
suggestive of myocardial &hernia. An ECG was considered 
Positive for &hernia when the changes were transient. 
The laboratory pathologist determined the fibrinopeptide A 
levels without knowledge of the clinical diagnosis or angio- 
graphic results. Coronary an&grams were evaluated ir;de- 
pendently by an experienced angiographep and an experi- 
enced cardiac radiologist who did not know the palients’ 
identity. clinical presentation and fibrinopeptide A results. 
All angiograms were reviewed for the degree of coronary 
artery stenoses and the presence of intracoronary thrombus 
formation and comp!ex lesion morphology. AH stenoses 
were meiuured with caiipers. In cases of disagreement the 
angmgrams were reviewed again and a consensus opinion 
was reached. 
Angiographic c&e& of intracarcaary tbro&us. An& 
grams were assessed for the presence offeLiures suggestive 
of ttrombus formation at the site of a sign&ant coronary 
stenosis: filling defects, contrast staining, haziness. ticgu- 
lanry. sharp or overhanging shoulders and complex lesion 
morphology (19.20). On the basis of these features. the 
angiograms were graded 0 to 4 for the probabikty ofthrom- 
bus: grade 4 ldcfinite thrombus) was the presence of a filing 
defect with contrast staining on at least three sides ircespec- 
liv: of the prerence of the ather features listed; grade 3 
tprobeble thrombusj was a probable filling defect nrcwtmst 
staining with or without the other features: grade 2 (possible 
thrombusl was the presence of at least two of the following 
features: harincss. irregularity. sharp shoulders or lesion 
ulcerations: grade 1 (low probability) was the presence of a 
single feature noted for grade 2; grade 0 (no tiomhw! C;Z 
the absence OT any of the nforemcnrbrted cliteria. 
Fibritqxplide A sample acqaSt&o. Urine for fibrino- 
peptide A determination was obtained as soon as possible 
after an episode of chest pain. and cardiac catheterization 
was carried out as soon as possible after sample acquisition. 
If the patient’s physician determined tha! !he clinical presen- 
tation warranted anticoagulant therapy, urine was obtained 
before anticoagulation. 
Sample collection. storage and urinary librinopeptide A 
assay techniques have previously been described (10). The 
containers whh urine were stored at -7(PC and shipped 
overnight on dry ice to Washington. D.C. where fibrinopep 
tide A ievels were determined. The samples remained frozen 
during transfer. The assay involves a polyclanal rabbit 
antibody method, which recognizes both the amino and 
carbaxyl ends of the tibrinopeptide A polypeptide. Phosphor- 
ylated ftbtinopeptide A is also detected by this assay. 
LIata analysis. Fibrinopeptide A results are expressed as 
nanograms of fibrinopeptide Almilligrams of urinary crcati- 
nine In&g 01. Fibrinowptide A data underwent logatith- 
mic transformation and the transformed variable was used 
for standard parametric statistical testing. Analysis for con- 
tinuous variables (Table I) used sna!ysis of variance 
[ANOVA) with a protected least significant difference (LSD) 
test for diBerences between the four groups. Kruskal-Wallis 
nonparametric ANOVA was used to analyze nonparametric 
variables with the Mann-Whitney U test utilized for differ- 
ences. The chi-square test was utilized when evaluating 
relations of clinical ECG or angiographic variables within 
groups. The Wilcoxon signed tank test was used to analyze 
agreement between the two observers concerning angio- 
graphic thrombus detection. Multiple regression analysis 
was utilized when evaluating the effect of clinical or angie 
graphic variables on Iibrinopeptide A levels. A p value C 
0.05 was considered significant. 
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Table 1. Patient Characleristics 
Group 2: 
Stab’- 
Angina 
I” = 191 
Gmup 3 
- 
A: B: New 
t-wscenda onsei Rest 
Angina A”@% 
,” = I#) (n = 24) 
Age IW 53.3 + 12.2 58.7 * 10.8 64.4 t 11.3 57.1 + 13.4 
Malelfemale ratio 712 ,415 ,414 I&% 
Aspirin urqe (no. of plientsl 5 IS 12 II 
Urea nitrogen (mddll 16.3 + 5.8 16.2 + 1.8 17.6 + 7.6 15.8 t 4.7 
Plarmn crealinine (m@dldl) II + 0.1 1.0 t Il.2 I.2 2 0.5 I.0 f 0.3 
Plalekls U%‘imm~) 341 + 115 277 f 64 252 * w 288 f 90 
Time I (hl 14.6 t 9.1 211 -4.5* IS.8 f 4s 13.0 + 8.9 
Time 2 (hl 4.5 i 11.8 1.7 t 5.4 9.9 ’ ‘1.0: Il.5 2 25.7t 
--__ 
*p< O.Wl.gloupZversusg,oup I andgroups3Aand38. tp< O.WI groups3A aad3Brerwsg,osj 1 andgroup 
2. There were no other rignificanr differences bw.?en the gwupr Time 1 rcpresenl~ Ihr rime bewecn the Ias1 
epirodeofchest pain md fibdnopeplide A wnpk acquisition. Time Znpresents the lime between sample acquisition 
and cardiac calhelerizalion. 
Results 
There were 70 patients (51 male, 19 female). Of these, 61 
were found to have coronary artery disease: 24 with rest 
angina of new onset, 18 with crescendo angina and 19 with 
stable angina. The remaining nine patients (control group) 
had chest pain suggestive of coronary artery disease but no 
coronary obstructions. Table 1 shows the characteristics of 
the f&patient groups. 
Fihrino@eptidc A results. Fibrinope-ptide A levels were 
significantly higher in the groups with rest angina of new 
onset (5.91 ? 0.72 nglmg Cr) and crescendo angina (6.39 z 
0.94 ndmg Cr) than in the group with stable angina (3.49 2 
0.33 ngimg Cr) or the control group (3.59 t 0.34, p = 0.002, 
Table 2). F’revious studies have determined 6.0 ngimg Cr as 
the upper limit of normal (IO). Nine (38%) of 24 patients with 
rest angina and 7 (39%) of I8 patients with crescendo angina 
pectotis had levels >6.0 ngimg Cr, whereas 2 (10%) of 19 
patients with stable angina pectoris exhibited small increases 
in fibrinopeplide A levels and no patient in the control group 
had an elevated Lbrinopeptide A level (p c 0.02, Fig. I). 
Angiographic rwdts. Angiographic signs of intracoro- 
nary thrombus were observed in 16 of 24 patients with rest 
angina of new onset (47%. p < 0.001 vs. stable and control 
groups) with I1 exhibiting a grade 3 to 4 thrombus (Table 3). 
In 9 of I8 uatients with crescendo angina (50%. o < 0.002 vs. 
control group) thrombus was visualized.’ Eighf of nine had 
grade 3 to 4 thrombus. Grade 4 thrombus formation was 
Table 2. Urinary Fibrinopeplide A Results 
Group I. Conirol (n = 9) 3.59 + 0.34 
Group 2: Stable angma ,n = IY, 3.49 f 0.33 
Group 34: Crescendo angina (n = 18) 6.39 f 0.94’ 
Group 38: New onset rest angina (n = 241 5.91 z 0.72’ 
‘p < II.WZ verw. values in groups I and 2. Results are expressed in ng 
Pbfinoprp’ide A/mg erealinine (mean t SE). 
more common in patients with angina of new onset (p = 
0.0041. The incidence of comniex lesion moroholoev in 
patients with rest angina approached but did’not kch 
statistical significance (p = 0.056. Table 3) when compared 
with that in patients with stable angina. There was no 
difference in Ihe number or the severity of diseased vessels 
between the groups with stable and unstable angina. No 
significant difference between the two observers for the 
detection of angiographic thrombus (p = 0.~74) was ob- 
served, and the agreement between the twoobservers on the 
initial reading of the angiogram was 77%. 
Fibrinopeptidr A-angiography mrddii. Fibrinopep- 
tide A levels correlated significantly with the presence of 
angiographically documented intracoronary thrombus (p < 
0.001, Fii. 2). Nine of the 16 patients with rest angina with 
tbrombus had elevated fibrinopeptide A levels as did 6 of the 
8 patients with crescendo angina with thrombus. In patients 
with grade 3 to 4 thrambus (n = 191, tibrinopeptide A levels 
averaged 8.32 + 1.00 nglmg Cr (p < 0.001 vs. no thrambus or 
grade I to 2). whereas tibrinoceptide A levels averaged 
b6 * 0.51 ngimg Cr in patients-with grade 1 to 2 thrombus 
(n = 19) and 3.72 -c 0.21 nglmg Cr in patients with grade 0 
thrombus 01 = 42). All patients with fibrinopeptide A levels 
>B nglmg Ct (n = 9) exhibited grade 3 or 4 intracoronary 
tbrombus formation on angiography. Among patients with 
unstable angina with levels Z~‘I ngImg Cr. 15 (94%) of 16 
exhibited thrombus on angiogrz shy with 13 exhibiting grade 
3 to 4 tbrombus formation. The results of clinical presenta- 
tion, fibrinopeptide A levels and an&graphic thrombus are 
shown in Table 4. 
Correlations among fibrinapeptide A and ECC and an&o- 
graphic findings. Twenty-two patients exhibited transient 
ECG changes indicative of ischemia, either ST segment 
depression or T wave inversion. All patients were in the 
unstable angina group and the mean fibrinopeptide A level 
was significantly increased at 7.71 k 0.91 ng/mg Cr (p < 
0.001) when compared with the level in patients in all groups 
c SA GA RA 
Fitwe 1. Graph showine tibrinowrrtide A levels from individual 
p&nls with~unstable angina &V onset rest angina [RAi UT 
piow~sive. crescendo angina [CA]). stable angina &II and control 
patienls with chest pain hut no coronary artery disease ICI. Pibri- 
nopeptide A levels are significantly higher in the group\ with 
unstable angina. 
who did exhibit ECG changes (3.45 -C 0.25. n = 481. Patients 
with unstable angina with ST depression had a mean fibrino- 
peptide A level of 8.00 f 1.24 ns/mg Cr In = IS. p i 0.0011. 
patients with T wave inversion had a mean level of 7.09 i 
1.14 ndmg Cr (n = 7) and patients with unstable angina 
without transient ECG abnormalities had a mean level of 
4.42 f 0.4s ngimg Cr (n = 19). Eight of 15 patients with ST 
changes showed elevated fibrinopeptide A levels as did 4 of 
7 patients with T wave inversion. Patients with transient 
ECG chances were more likclv than oatients without such 
I . 
changes to have grade 3 to 4 an&graphic thrombus (p < 
0.001). All patients with elevated fibrinopepride A levels and 
ECG changes demonstrated angiographic thrombus furma- 
tion. 
Olher cormlatioas. Mul!iple regression stepwisc analysis 
showed that none of the following variables correlated with 
fibrinopeptide A levels: age. gender. aspirin usage. white 
blood cell count, platelet count. +sma urea nitrogen. cre- 
atinine or glucose levels. previous coronary artery bypass 
Discussion 
The results of the present study evaluming the clinical 
presentation of unstable angina. spot urinary fibrinopeptide 
A levels and angiographic signs of ihrombus are fourfold: 
II elevated Cbrinopeptide A levels correlated with and 
predicted the presence of intracoronary thrombus on coro- 
nary angiograms; 2) active thmmhus formation was present 
both in patients with new onset rest anginaand in those with 
progressive. crescendo angina: 3) transient ECG changes 
correlated uith the presence of elevated fibrinopeptide A 
Icvcls and angiogrdphic thrombus; and 41 a substantial 
minority of patientc with tmstablc- angina exhibited neither 
tttt elevated Fibrbtopeptide A level nor a&graphic throm- 
bus. Results of the current study differentiated patients on 
the basis of the presence of angiographic thrombus or 
elevated fibrinopeptide A levels (Table 4). or both. and 
subsranriate previous data showing that some patients with 
rest angina do not have angiographically defined thrombus 
fommrion (l.4.N or an elevated fibrinopeptide A value 
17-10). The results illustrate the heterogeneous and dynamic 
pathophysiology of unstable angina. 
Intracomnary thrombtts formation. Thrombus formation 
in unstable angina initially develops as a result of platelet 
adhesion IO a fissured atherosclerotic plaque (18.33). Plate- 
111 - 
II - 
14 - 
o- 
Figure 2. tiraph dlustrnting the relatiunship between angiographic 
grade of intracoronary artery thrombus formation and librinopeptide 
A levels. The presence of a grade 3 or 4 thtombur correlated 
significantly with an elevated tibrinopeptide A level. See Methods 
for definition of lhrombus grades. 
lets may then aggregate, leading to an initial platelet throm- 
bus with little fibrin deposition, as autopsy studies (18) of 
patients with unstable angina who had died suddenly have 
shown. The platelet thrombus may dislodge and dissipate 
Table 4. Correlation of Angiographic Findings and Elevated 
Fibrinopeptide A Levels 
Group 2: 
Gmup 3 
Group t: Stable A: Crtrcendo B: New Onset 
Control Angina AlIgllla Rest Angina 
I” = 91 In = 191 lo = IS) ,n = 24) 
STHR. +FPA 0 0 6 9 
+THR. -FFA 0 3 3 7 
-THR, +FPA 0 2 I 0 
-THR. -FPA 9 14 8 S 
-FPA and +FPA = fibrinopeptide A level <6.0 and 26.0 n&g creali- 
nine. respectively: -lHR and tTHR = absence and presence. resprctivcly, 
of any grade of inlracoronary thrambur follliatlon by angiagmphy. 
(34) leaving no angiographic or fibrinopeptide A evidence of 
its prcsencc. However. thromboxane A,, serotonin and 
adenosine diphosphate released from platelet aggregates 
(12-14) can cause local vasospasm (35) and reduce coronary 
Row leading to myocardial ischemia (Fig. 3). Alternatively. 
platelet aggregates may consolidate fibrin, thereby produc- 
ing a partially or totally occlusive arterial thrombus. This 
step would be reflected by an increase in librinopeptide A 
levels. The fibrin thrombi may then undergo endogenous 
fibrinolysis or incorporation into the atherosclerotic plaque 
(16.36). The fibrinolvtic ohase would not show a fibrinooeo- . . 
tide A elevation and an~ographically the lesion may appear 
as a complex lesion (19,ZO). Thus, an elevated ftbrinopeptide 
A vahte or the presence of angiographic signs of intracoro- 
nary thromhus formation would depend on the particular 
stage of thrombus development. 
Flbrinopeptide A-angiography correlation. Our data indi- 
cate that patients with unstable angina, due to either rest 
angina or crescendo angina, can be classified into subsets 
depending on the presence of either active or quiescent 
thrombus (Table 4). We hypothesize that thoss patients who 
bad both an elevated fibrinopeptide A level and angiographic 
signs of tbmmbus bad active thrombus formation. Patients 
who had angiographically defined thrombus formation but 
normal fibrinopeptide A levels may have had quiescent 
thrombus formation at the time of sampling or possibly 
platelet aggregates without fibrin consolidation. The possi- 
bility that a transient elevation of fibrinopeptide A was 
missed cannot be excluded. The absence of elevated fib& 
nopeptide A levels in seven of nine patients with grade I to 
2 angiographic thromhus may indicate that those angio- 
graphic criteria do not adequately reflect ongoing intracoro- 
nary artery thrombus formation and are oversensitive mark- 
ers. In patients with neither an elevated fibrhtopeptide A 
level nor angiographically defined intracoronary artery 
thrombus formation (8 of 24 patients with rest angina and 8 
of IX patients with crescendo angina), the pathaphysiology 
of the symptoms of unstable angina may have resulted from 
dynamic platelet aggregation and disaggregation with inter- 
mittent release of vasoactive substances (Fig. 3). lr, those 
patients with crescendo angina without evidence of throm- 
bus, platelet aggregates may have led to progressive coro- 
nary stenosis (36) and the angina may have been a result of 
subsequently reduced coronary flow in the setting of in- 
creased oxygen demand. The clinica; differentiation of fibrin 
from platelet thrombi is important because fibrin thrombi are 
more sensitive than platelet thrombi to thrombnlytic therapy 
(37) and new therapies targeting oniy fibrin thrombi or 
platelet aggregation are forthcoming. !n addition, patients 
with angiographically document,:d intracoronary thrombus 
fmmation respond better to thrombolytic therapy than do 
patients without this finding (2,X,23). 
The lack of angiographic or biochemical evidence of 
thrombus in some patients with unstable angina may explain 
why previous studies evaluating the cse of thrombolytic 
therapy during ongoing unstable attacks of angina pectoris 
Figure 3. Proposed pathophysiologic proceu uf in- 
lracaronary artcry :hrombus formation in unstable 
angina. After fissuring of an atherosclerulic plaque. 
plalelet adhesion ocwrs that can progress to aggre- 
gation. The plarelet aggegales may rpantaneourly 
disaggregafe or re!eare vasoactive substances ifor 
example, sermonin IS-HT] or thromboxane .4, 
IiXA21L which leads to XII increase in vascular tone 
and subsequent myocardial &hernia. Adcnoaine 
diphosphate (ADP) releaed from pla&lct gmnules 
can cause increased aggregation. The plateler a&gre- 
gate may also mwwxate fibrin. leadmg to a fibrin- 
rich arterial thrombus. This step uwdd be rcflccted 
by an increase in fibrinopeptidc A CFPAI. The arte- 
rial thrombus can occlude or partially occlude Ihc 
artery, leading to increased &hernia. Alternatively 
il can undergo spontaneous endogenous thromboly. 
4s. Thus. myocardial lschcmia may rellscl ths pres- 
ence of either plalelet aggregates or fibrin-rich 
thrombi. 
have shown clinically and angiographically inconsistem re- 
sults (2,3,23.24.38.39). In theory. fibnnopeptide A levels 
may help select those patients with unrbable angina who 
would benetit from !hrombolytic therapy. Also. fibrinopep- 
;iZc A Ievelc could possibly be used IO determine which 
patients with unstable angina may benefit from long-term 
anticoagulation to reduce the frequency of angina1 attxkh. 
Tne use of a biochemical marker and angiography to 
detect thrombus involves two techniques that are not di- 
rectly comparable. Fibrinopeptide A is produced only during 
active thrombus formation and leve!s are therefore dynamic. 
A normal fibrinopeptide A level indicates that there is no 
ongoing thrombus formation but does not exclude the pres- 
ence of a quiescent thrombus. Conversely, the angiogram 
indicates the presence of a thmmbus. whether active or 
quiescent. Angiography may be an insensitive method for 
the diagnosis of intracoronary thmmbus formation because 
studies comparing angiognphic and nngiorcopic detection of 
thrombus formation in patients with unstable angina have 
shown that thrombus was detected more frequently by direct 
visualization with the use of angioscopy (6.40). However. 
the definition of angioscopic thrombus includes both munl 
and intraluminal thrombi (40). Thus, small mural thrombi 
observed by angioscopy may escape detection by coronary 
angiography. Of interest. was the finding that grade 3 to 4 
anglographic thmmhus (that is. filling defects or contrast 
staining) correlated strongly with elevated fibrinopeptide A 
levels. Thus, angiography may be sensitive in the detection 
of active intraluminal thmmbi. 
Predictive v&e of ECG changes. Our results substantiate 
findings by Eisenberg et al. (I II showing that transient ECG 
changes in patients with unstable angina correlate with 
fibrinopeptide A elevations. Approximately 55% of patients 
with unstable angina with either ST changes or T wave 
inversions showed elevated Rbrinopeptide A levels. a pro- 
portion similar to that seen by Eisenberg and colleagues in 
patients with unstable angina with reversible ST segment 
shifts. The observalion that the combination of an elevated 
fibrinopeptide A level and transient ECG changes predicted 
angiographic thrombus in all cases whether crescendo or 
new onset rest angina may indicate a noninvasive clinical 
strategy to predict active thrombus formation. 
Excretion oE tibriwpeptide A. The short half-life of 
plasma librinopcptide A has limited the clinical utilhy of this 
assay in evaluating active thmmbus formation. We elected 
to evaluate urinary ftbrinopeptide A levels because the 
polypeptide is stable in urine and a spot urine sample 
renresents a filtered samde collected over time. thereby 
increasing the yield. Urinary tibrinopeplide A levals co& 
late with concurrently obtained plasma Ievels 128-31). How- 
ever. the urinary excretion of fibtinopeptide A is incom- 
pletely understood in the setting of unstable an&a and is a 
uoremial limhation of the current studv. BallLard et al. (29) 
have shown that after a bolus injecdon of serum pIarm; 
fibriqopeptide A. levels in healthy individuals exhibit a 
double exponential decay curve with anearly half-time of I .5 
to 4 min with subsequent return to normal levels in 2 h. 
Concurremly obtained urine samples showed a peak fibrin+ 
peptide A level at 10 min after serum injection and elevated 
fibrinopeptide levels were observed for up to 4 h. When 
patients underwent serum infusion over 60 min. a scenario 
that may more closely imirare the clinical state of fibrinopep 
tide A release in patients with unstable angina, urinary 
Rbrinopeptide A levels increased within 30 min and remained 
elevated for 7 h (29). The urinary level of fibrinopeptide A is 
dependent on the amount of thrombus formation and the 
duration of thmmbin activity. That we did not observe a 
relation between the level of librinopeptide A and the 
time after the onset of chest pain is not unexpected be- 
cause we have observed (unpublished observations) that 
increases in fibrinopeptide A may precede chest pain. It is 
possible, however, that an episode ofangina resulting from a 
small rhrombus may not have led to an increase in the 
frbrinopeptide A Ieve! high enough for detection; thus, some 
small elevations of fibrinopeptide A may have missed detrc- 
tion. 
Conclusions. In summary. the presence of elevated fi- 
brinopeptidc A levels obtained within 24 h of an episode of 
unstable angina correlated with the presence of inlracoro- 
nary thrombus formation on coronwy angiography. Approx- 
imately 67% of patients with rest angina and 50% of those 
with crescendo angina showed angiographic evidence of 
thrombus and virtually all patients with unstable angina with 
an ele;ated fibrinopeptide A value showed angiqrapbic 
thrombus. Transient ECG ST segment depression in patients 
with rest or crescendo angina correlated with elevated 
fibrinapeptidc A levels and angiographic thrombus. All pa. 
tients with transient ECG changes and elevated Abrinopep- 
tide A levels had angiographic thrombus. However, some 
oatients showed neither elevations in fibrinooeotide A no, . . 
angiographic evidence of thrombus. These patients may not 
have had fibrin thmmbus formation and therefore would not 
be optimal candidates for thrombolytic therapy. The pres- 
ence of transient ECG changes and elevated fibrhtopeptide A 
levels in patients with either rest angina of new onset or 
crescendo angina may indicate those patients with aclive 
thrombus formation. 
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